Lv4
580 积分 2023-07-13 加入
Balancing Reactivity and Specificity: Fc-Binding O-Acyl Hydroxamate Reagents for Site-Selective Antibody Labeling at Lys248
1个月前
已完结
177Lu-PSMA-617 versus a change of androgen receptor pathway inhibitor therapy for taxane-naive patients with progressive metastatic castration-resistant prostate cancer (PSMAfore): a phase 3, randomised, controlled trial
1个月前
已完结
A monoclonal antibody targeting nonjunctional claudin-1 inhibits fibrosis in patient-derived models by modulating cell plasticity
1个月前
已完结
Claudin proteins as emerging therapeutic targets for solid tumours
1个月前
已完结
Claudin-1 is a mediator and therapeutic target in primary sclerosing cholangitis
2个月前
已完结
Designing stable humanized antibodies
2个月前
已完结
The THP-1 cell line as a model for the assessment of monoclonal antibodies aggregates’ immunological effects
4个月前
已完结
Anti-melanoma Effects of Resiquimod (RSQ) In Vitro and in Combination with Immune Checkpoint Blockade In Vivo
4个月前
已完结
Binding patterns of DTR-specific antibodies reveal a glycosylation-conditioned tumor-specific epitope of the epithelial mucin (MUC1)
5个月前
已完结
What Makes MUC1 a Tumor Antigen?
5个月前
已完结
皖公网安备34019202002308
